Drugs / Compound Ipratropium Bromide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04101500 Background | Apr 2019 → Dec 2020 | chronic obstructive pulmonary disease | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound Ipratropium Bromide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04101500 ↗ |
| Route | Inhaled | “2.5ml atomized inhalation twice a day” NCT04101500 ↗ |